home / stock / poet / poet news


POET News and Press, POET Technologies Inc. From 05/15/23

Stock Information

Company Name: POET Technologies Inc.
Stock Symbol: POET
Market: NASDAQ
Website: poet-technologies.com

Menu

POET POET Quote POET Short POET News POET Articles POET Message Board
Get POET Alerts

News, Short Squeeze, Breakout and More Instantly...

POET - POET Technologies Reports First Quarter 2023 Financial Results

TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the dat...

POET - POET Technologies scales 8% on securing first volume purchase order for optical engines

2023-05-11 08:06:59 ET POET Technologies ( NASDAQ: POET ) price trades 7.7% higher on Thursday pre-market as it announced the first volume production order for its optical engines placed with the company’s 80%-owned joint-venture company, Super Photonics Xiamen...

POET - POET Technologies Announces First Volume Purchase Order For Its Optical Engines

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET | TSXV: PTK), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) and light sources for the data center, t...

POET - The Power Play by The Market Herald Releases New Interviews with Hispania Resources, POET Technologies and Nextech3D.ai Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / April 25, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Hispania Resources, POET Technologies and Nextech3D.ai discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapshot of...

POET - LAZR, ARWR and BXRX among pre-market gainers

2023-04-25 08:29:42 ET Baudax Bio ( BXRX ) +74% announces positive top-line final results from phase 2 randomized clinical trial of BX1000. Morphic Holding ( MORF ) +34% as lead asset meets key goal in mid-stage trial. CXApp ( CXAI ) +32% . ZeroFox ...

POET - LAZR, ARWR and BXRX among pre-market losers

2023-04-25 08:29:42 ET Baudax Bio ( BXRX ) -74% announces positive top-line final results from phase 2 randomized clinical trial of BX1000. Morphic Holding ( MORF ) -34% as lead asset meets key goal in mid-stage trial. CXApp ( CXAI ) -32% . ZeroFox ...

POET - POET Technologies Introduces "POET Starlight" for the Artificial Intelligence Market and Receives Advanced Purchase Order from Celestial AI

TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunicati...

POET - POET Technologies Expands Investor Outreach Efforts

TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the d...

POET - POET Technologies GAAP EPS of -$0.17 misses by $0.07, revenue of $0.2M beats by $0.1M

2023-04-03 01:19:33 ET POET Technologies press release ( NASDAQ: POET ): Q4 GAAP EPS of -$0.17 misses by $0.07 . Revenue of $0.2M beats by $0.1M . Cash flow from operating activities in the fourth quarter of 2022 was -$2.7M compared to -$3.2M in the fourth quar...

POET - POET Technologies Reports Fourth Quarter 2022 Financial Results

TORONTO, March 31, 2023 (GLOBE NEWSWIRE) --  POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for...

Previous 10 Next 10